Cannabis

Medical cannabis in chronic pain management

Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.

High stakes: Is the UK finally clearing a pathway for cannabis investments?

John Binns, Partner at BCL Solicitors LLP says it’s high stakes when it comes to the UK finally clearing a pathway towards cannabis investments.

Ensuring regulatory compliance for Medical Cannabis

Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.

CBD oil for pain: What the research shows

Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.

Will 2021 see the UK’s cannabis industry bloom?

John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.

CBD oil for ADHD: What the research shows

CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.

Cannabis as a treatment for COVID-19

Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.

CBD Novel Foods in the UK

Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.

Cannabidiol, skin homeostasis and acne

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.

The UK’s legalisation of medicinal cannabis

David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.

Medical cannabis in the UK and the industry’s future

Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.

Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine

Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.

Functionality of Hemp Proteins and their Peptides

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.

Innovative Pioneers of the Hemp Trade

Elixinol, Merges Water-Soluble Technology with THC-Free CBD in a New Range of CBD Blended Tinctures.

The use of medical cannabis in the UK

Andreas Met, COO, Compliance and Director at Halo Labs highlights how the use of medical cannabis is on the rise in the UK and could offer relief to many NHS patients.

A medical professional’s opinion on medical marijuana

Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.

The priorities for cannabis research

Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders